Tag: SGLT2 inhibitor
Canagliflozin and Amputation Risk: What You Need to Know Now
Canagliflozin increases the risk of foot and leg amputations in certain people with diabetes. Learn who’s at risk, how to prevent complications, and how this drug compares to other SGLT2 inhibitors like Jardiance and Farxiga.
Read More
0 Comments